Search company, investor...
Search

Predict your next investment

Agilent Technologies company logo
Corporation
COMPUTER HARDWARE & SERVICES | IT Services / IT Solutions & Software Development
agilent.com

See what CB Insights has to offer

Investments

32

Portfolio Exits

7

Partners & Customers

10

About Agilent Technologies

Agilent Technologies (NYSE: A) provides instruments, software, services, and consumables for the entire laboratory workflow, serving the life sciences, diagnostics, and applied chemical markets. The company was founded in 1999 and is based in Santa Clara, California.

Agilent Technologies Headquarters Location

5301 Stevens Creek Boulevard

Santa Clara, California, 95051,

United States

408-345-8886

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Agilent Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Agilent Technologies in 3 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

382 items

M

Medical Devices

3,868 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

H

Health Monitoring & Diagnostics

76 items

Companies developing companion diagnostics and technology enabling the development of companion diagnostics. Tagged as #CompanionDx

Agilent Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Agilent Technologies Rank

Research containing Agilent Technologies

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Agilent Technologies in 1 CB Insights research brief, most recently on Sep 12, 2022.

Latest Agilent Technologies News

Companion Diagnostics Global Market to Reach $9.99 Billion by 2026 at a CAGR of 18.01%

Sep 29, 2022

Dublin, IRELAND Dublin, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The "Companion Diagnostics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global companion diagnostics market is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The companion diagnostics market is expected to reach $9.99 billion in 2026 at a compound annual growth rate (CAGR) of 18.01%. North America was the largest region in the companion diagnostics market in 2021. The regions covered in the companion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The increasing number of targeted therapies is expected to propel the growth of the companion diagnostics market. Targeted therapy is a pharmacological therapy that targets particular characteristics of cancer cells to inhibit the growth and spread of the disease. The medications circulate throughout the body but have a more targeted effect than chemotherapy and frequently have fewer adverse effects. Biological marker-based companion diagnostic testing for targeted cancer therapy is becoming an essential part of personalized cancer care. According to the April 2021 article of European Society for Medical Oncology, the genome-targeted therapy estimated eligibility was 8.82% by the end of 2018 and increase to 13.60% in 2020. Therefore, the rising number of therapies drives the companion diagnostics market. Technological advancement is a key trend in the companion diagnostics market. Artificial intelligence is used to develop more efficient drugs for companion diagnostics. The continuously gathered massive data sets from diverse genetic profiling have enabled the widespread application of AI. For instance, Deep Genomics, a Toronto-based start-up, is utilizing artificial intelligence to uncover better medications for genetic illnesses and speed up their introduction into clinical trials. The goal is to employ deep learning to explore the human genome for knowledge about the causes of diseases and to create and test chemical compounds that can be used as remedies. In a computer model, deep learning enables scientists to test billions of chemical compounds in search of promising formulations that they can turn into medicines that save lives for people worldwide. In April 2021, Agilent Technologies Inc., a US-based Analytical laboratory company that manufactures instruments, reagents, software, services, and consumables for comprehensive laboratory workflow, acquired Resolution Bioscience for $695 million. With this acquisition, Agilent's strengths in NGS-based cancer diagnostics are complements and expands, and also gives the company access to technology to meet the demands of the rapidly expanding precision medicine sector. Resolution Bioscience is a US-based healthcare research company specializing in NGS technology, molecular biology, cancer diagnostics, and more. Scope

Agilent Technologies Investments

32 Investments

Agilent Technologies has made 32 investments. Their latest investment was in Halo Labs as part of their Series C on July 7, 2022.

CBI Logo

Agilent Technologies Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/11/2022

Series C

Halo Labs

$6M

Yes

7

3/15/2022

Series B

Arima Genomics

$7M

Yes

6

3/15/2022

Series B - II

Molecular Assemblies

$25.8M

No

4

1/11/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/16/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/11/2022

3/15/2022

3/15/2022

1/11/2022

12/16/2021

Round

Series C

Series B

Series B - II

Series A

Series A - II

Company

Halo Labs

Arima Genomics

Molecular Assemblies

Subscribe to see more

Subscribe to see more

Amount

$6M

$7M

$25.8M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

6

4

10

10

Agilent Technologies Portfolio Exits

7 Portfolio Exits

Agilent Technologies has 7 portfolio exits. Their latest portfolio exit was Akoya Biosciences on April 16, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/16/2021

IPO

$99M

Public

1

3/29/2021

Acq - Pending

Subscribe to see more

$99M

Subscribe to see more

10

7/18/2018

Acquired - III

Subscribe to see more

$99M

Subscribe to see more

10

1/20/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/3/2010

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/16/2021

3/29/2021

7/18/2018

1/20/2017

2/3/2010

Exit

IPO

Acq - Pending

Acquired - III

Acquired

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Agilent Technologies Acquisitions

34 Acquisitions

Agilent Technologies acquired 34 companies. Their latest acquisition was Polymer Standards Service on August 02, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/2/2022

$99M

Acquired

1

3/2/2021

$99M

Acquired

13

7/11/2019

$99M

Acquired

6

9/26/2018

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

6/28/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/2/2022

3/2/2021

7/11/2019

9/26/2018

6/28/2018

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

13

6

10

10

Agilent Technologies Partners & Customers

10 Partners and customers

Agilent Technologies has 10 strategic partners and customers. Agilent Technologies recently partnered with Scitara on September 9, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

9/20/2022

Partner

United States

Scitara Announces Partnership With Agilent to Benefit Customers With Enhanced Digital Lab Connectivity

The announcement enables the integration of Scitara 's Scientific Integration Platform SIP with Agilent 's Software and Informatics Division portfolio of products , including chromatography software and lab workflow management solutions .

2

8/17/2022

Client

United States

Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions for Mytide’s Next-generation Manufacturing Platform

BOSTON -- -- Mytide Therapeutics , a company transforming peptide manufacturing with predictive analytics and machine learning , has partnered with Agilent , a global leader in life science , diagnostic and applied chemical markets .

1

2/22/2022

Licensee

United States

Element Biosciences Partners with Agilent Technologies to Validate SureSelect™ Target Enrichment Panels on Element’s AVITI™ System

Our partnership with Agilent Technologies has validated our AVITI system with the SureSelect hybrid-capture target enrichment solutions , '' said Shawn Levy , Senior Vice President of Applications and Scientific Affairs , Element Biosciences , Inc. .

1

2/17/2022

Distributor

United States

Subscribe to see more

Subscribe to see more

10

2/3/2022

Partner

Canada

Subscribe to see more

Subscribe to see more

10

Date

9/20/2022

8/17/2022

2/22/2022

2/17/2022

2/3/2022

Type

Partner

Client

Licensee

Distributor

Partner

Business Partner

Country

United States

United States

United States

United States

Canada

News Snippet

Scitara Announces Partnership With Agilent to Benefit Customers With Enhanced Digital Lab Connectivity

The announcement enables the integration of Scitara 's Scientific Integration Platform SIP with Agilent 's Software and Informatics Division portfolio of products , including chromatography software and lab workflow management solutions .

Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions for Mytide’s Next-generation Manufacturing Platform

BOSTON -- -- Mytide Therapeutics , a company transforming peptide manufacturing with predictive analytics and machine learning , has partnered with Agilent , a global leader in life science , diagnostic and applied chemical markets .

Element Biosciences Partners with Agilent Technologies to Validate SureSelect™ Target Enrichment Panels on Element’s AVITI™ System

Our partnership with Agilent Technologies has validated our AVITI system with the SureSelect hybrid-capture target enrichment solutions , '' said Shawn Levy , Senior Vice President of Applications and Scientific Affairs , Element Biosciences , Inc. .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Agilent Technologies Team

19 Team Members

Agilent Technologies has 19 team members, including current Managing Director, David Hwang.

Name

Work History

Title

Status

David Hwang

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

David Hwang

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Managing Director

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You May Also Like

Genomind Logo
Genomind

Genomind is a personalized medicine company committed to the discovery of the underlying causes of neuropsychiatric disorders and supporting the development of personalized medicine that improves patients' lives. The company offers a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness.

SantoLubes Logo
SantoLubes

SantoLubes is a chemical manufacturer that manufactures and supplies santovac, santotrac, santolube, synthetic fluids, greases, and electronic lubricants for the aviation, aerospace, and electronics sectors. It is located in Spartanburg, South Carolina.

Angstrom Sciences Logo
Angstrom Sciences

The firm aims to help the company's customers create the most productive and cost-effective thin-film applications possible - by delivering the world's most advanced magnetrons, a range of deposition materials, and a program of technical support.

Caris Life Sciences Logo
Caris Life Sciences

Caris Life Sciences is an Irving, Texas-based provider of molecular science that assess DNA, RNA and proteins to reveal a molecular blueprint that allows physicians and cancer patients to make precise and personalized treatment decisions.

CellChorus Logo
CellChorus

CellChorus provides a dynamic analysis of single cells. The company’s TIMING platform applies visual AI to evaluate cell activation, killing, and movement as a function of time in order to maximize our understanding of cellular function, state, and phenotype.

B
Becker Pumps

Becker Pumps is a manufacturer of vacuum pumps, compressors and regenerative blowers. Becker Pumps provides sales, service and replacement parts across the US, Canada and Mexico.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.